Treatment Category Profile

Treatment Name:	Arsenic Trioxide	Known as: Also Known As:	Arsenic-Trioxide
Treatment Type:	Anti-Angiogenesis	Status:	FDA Approved (phase II)
Treatment with low doses of this compound part of the family called antineoplastics have been found to induce remission in patients with acute promyelocytic leukemia. It interferes with cell growth, and may impact normal cells in addition to cancer cells.

   Articles related to this Treatment

	1 Sudden Deaths and Torsades de Pointes Draw Look at Arsenic Trioxide Safety Oncology Week in Review Jul 12, 2001